ACE inhibitors are known to accumulate bradykinin levels leading to angioedema development; however, considering anaphylaxis, it is thought that ACE inhibitors, as well as beta-blockers, may act through activation of the high-affinity IgE receptor FcεRI [43]. The gene discussed is ACE; the disease is angioedema.